Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non–High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts-Reference-Cited by-同舟云学术

Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non–High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts

Published:2019-08 Issue:8 Volume:19 Page:516-521
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Adrianzen Herrera Diego,Kornblum Noah,Derman Olga,Bachier-Rodriguez Lizamarie,Sica R. Alejandro,Shastri Aditi,Janakiram Murali,Verma Amit,Braunschweig Ira,Mantzaris Ioannis

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference35 articles.

1. Improved outcome for AML patients over the years 2000-2014;Bertoli;Blood Cancer J,2017

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Dohner;Blood,2017

3. Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types;Yoon;Oncotarget,2017

4. Post-remission therapy for acute myeloid leukemia;Schlenk;Haematologica,2014

5. Hematopoietic stem cell transplantation for patients with AML in first complete remission;Cornelissen;Blood,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care;Transplantation and Cellular Therapy;2023-07